Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastases.

Minesh P. Mehta, Walter J. Curran, Ding Wang, Fen Wang, Lawrence Kleinberg, Anthony M. Brade, Nael Mostafa, Xiangdong Zhou, Jiang Qian, Terri Leahy, Bhardwaj Desai, Vincent L. Giranda

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of Clinical Oncology
StatePublished - Jan 31 2017

Disciplines

  • Pharmacology
  • Medicine and Health Sciences
  • Surgery
  • Other Medical Specialties

Cite this